Sign up to save your podcasts
Or
Share JAMA Dermatology : Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab vs Ipilimumab Alone for Unresectable Melanoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Dermatology : Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab vs Ipilimumab Alone for Unresectable Melanoma
Interview with Ivo Abraham, PhD, author of Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Ivo Abraham, PhD, author of Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma
More shows like JAMA Network
View all
Science Magazine Podcast
806 Listeners
JAMA Editors' Summary
129 Listeners
HBR IdeaCast
208 Listeners
NEJM This Week
317 Listeners
JAMA Author Interviews
163 Listeners
JAMA Clinical Reviews
485 Listeners
AFP: American Family Physician Podcast
683 Listeners
JAMA Pediatrics Editors' Summary
37 Listeners
Frankly Speaking About Family Medicine
255 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Psychiatry Author Interviews
23 Listeners
JAMA Surgery Author Interviews
6 Listeners
JAMA Medical News
86 Listeners
The Indicator from Planet Money
9,534 Listeners
Annals On Call Podcast
179 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
322 Listeners
Cardionerds: A Cardiology Podcast
407 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
19 Listeners
AMA Update
99 Listeners
NEJM AI Grand Rounds
50 Listeners